Hydroxyurea is an antimetabolite medication primarily used to reduce painful crises in sickle cell anemia and manage certain cancers.
Hydroxyurea is a synthetic, oral medication that belongs to the class of antimetabolite agents. It works by interrupting the growth of certain cells, especially those that divide quickly. In Hong Kong, hydroxyurea is available only with a prescription and is listed under the Pharmacy and Poisons Board’s controlled substances. The drug appears in products such as Hydrea.
The principal product containing hydroxyurea in Hong Kong is Hydrea (hydroxyurea tablets). It is marketed in several strengths, most commonly 500 mg and 1 g tablets, and is sold under its generic name as well as the brand name Hydrea. The tablets are taken by mouth and are the typical formulation used for the conditions described below. Other combination tablets that include hydroxyurea are not currently registered in Hong Kong, so Hydrea remains the main option for patients prescribed this ingredient.
These uses are approved by the Hong Kong Department of Health. In some cases, clinicians may consider hydroxyurea for other blood-cell disorders, but such decisions are made on an individual basis.
Hydroxyurea interferes with the ability of cells to copy their DNA, which slows down the division of rapidly multiplying cells. By limiting this process, the drug reduces the number of abnormal blood cells that cause disease symptoms. In sickle-cell disease, the same action also allows the body to produce more fetal haemoglobin, which keeps red cells flexible. Effects usually become noticeable after several weeks of regular use, rather than instantly.
These reactions are generally short-lasting and often improve as the body adjusts to the medication.
If any of these occur, seek urgent medical help.
For a complete list of potential interactions, refer to the detailed information supplied with each specific product.
Store Hydrorea tablets in a cool, dry place away from direct sunlight and out of reach of children. The medication is generally prescribed for a defined period-either short-term for a cancer-related protocol or long-term for chronic blood disorders-depending on the individual's condition. Always follow the instructions that come with the specific medicine and keep the prescribing clinician informed of any new symptoms or concerns.
For detailed usage, dosing, administration, and monitoring, refer to the information provided with your particular medication.
This article offers general educational information about hydroxyurea as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing hydroxyurea may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.